No Data
Shaanxi Meibang Pharmaceutical Group Co., Ltd. Report for the Third Quarter of 2024
Announcement of major operating data for the third quarter of 2024 of Shaanxi Meibang Pharmaceutical Group Co., Ltd.
Meibang Shares (605033.SH): net income in the first three quarters was 43.276 million yuan, a year-on-year decrease of 38.34%.
GeLongHui on October 29th: Meibang Stock(605033.SH) released its third-quarter report, with a revenue of 0.62 billion yuan in the first three quarters, a year-on-year increase of 12.49%, a net income of 43.276 million yuan, a year-on-year decrease of 38.34%, a non-net profit of 31.37 million yuan, a year-on-year decrease of 52.62%, and an EPS of 0.32 yuan.
Meibang Shares (605033.SH) released its performance for the first three quarters, with net income of 43.2762 million yuan, a year-on-year decrease of 38.34%.
Meibang Shares (605033.SH) released the third quarter report for the year 2024, during the reporting period the company achieved revenue...
Meiban Shares (605033.SH): 0.101 billion shares of restricted stocks will be released on September 18.
On September 10, GeLonghui announced that the total number of shares listed this time for Meibang shares (605033.SH) is 0.101 billion shares. The date of this stock listing is September 18, 2024.
Shaanxi Meibang Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report
No Data
No Data